Aldehyde Dehydrogenase and Aldo-Keto Reductase Enzymes: Basic Concepts and Emerging Roles in Diabetic Retinopathy
Open Access
- 21 July 2023
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 12 (7) , 1466
Abstract
Diabetic retinopathy (DR) is a complication of diabetes mellitus that can lead to vision loss and blindness. It is driven by various biochemical processes and molecular mechanisms, including lipid peroxidation and disrupted aldehyde metabolism, which contributes to retinal tissue damage and the progression of the disease. The elimination and processing of aldehydes in the retina rely on the crucial role played by aldehyde dehydrogenase (ALDH) and aldo-keto reductase (AKR) enzymes. This review article investigates the impact of oxidative stress, lipid-derived aldehydes, and advanced lipoxidation end products (ALEs) on the advancement of DR. It also provides an overview of the ALDH and AKR enzymes expressed in the retina, emphasizing their growing importance in DR. Understanding the relationship between aldehyde metabolism and DR could guide innovative therapeutic strategies to protect the retina and preserve vision in diabetic patients. This review, therefore, also explores various approaches, such as gene therapy and pharmacological compounds that have the potential to augment the expression and activity of ALDH and AKR enzymes, underscoring their potential as effective treatment options for DR.Keywords
Funding Information
- The Republic of Turkey Ministry of National Education (EU GA 847749, 18/0005791)
- RECOGNISED consortium (EU GA 847749, 18/0005791)
- Diabetes UK (EU GA 847749, 18/0005791)
This publication has 181 references indexed in Scilit:
- Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary VectorsHuman Gene Therapy, 2011
- Diabetes-related adduct formation and retinopathyJournal of Ocular Biology, Diseases, and Informatics, 2011
- Posttranslational modification and regulation of glutamate–cysteine ligase by the α,β-unsaturated aldehyde 4-hydroxy-2-nonenalFree Radical Biology and Medicine, 2011
- The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathyDiabetologia, 2010
- Mitochondrial aldehyde dehydrogenase and cardiac diseasesCardiovascular Research, 2010
- Retinoic acid signaling in mammalian eye developmentExperimental Eye Research, 2009
- Protein Modification by Acrolein: Formation and Stability of Cysteine AdductsChemical Research in Toxicology, 2009
- Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the HeartScience, 2008
- The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenalArchives of Biochemistry and Biophysics, 2008
- Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitorsBritish Journal of Pharmacology, 2008